CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sepp-Lorenzino, L.
Right arrow Articles by Lebwohl, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sepp-Lorenzino, L.
Right arrow Articles by Lebwohl, D. E.

Cell Growth & Differentiation, Vol 5, Issue 10 1077-1083, Copyright © 1994 by American Association of Cancer Research


ARTICLES

Insulin and insulin-like growth factor signaling are defective in the MDA MB-468 human breast cancer cell line

L Sepp-Lorenzino, N Rosen and DE Lebwohl
Breast and Gynecologic Service, Memorial Sloan Kettering Cancer Center,New York, New York 10021.

Polypeptide growth factors including the insulin-like growth factors (IGFs), insulin, and transforming growth factor-alpha are mitogens for many breast cancer cell lines and may act as regulators of cancer cell growth. In a human breast cancer cell line MCF-7, which expresses IGF-I receptor (IGF-IR), stimulation with insulin or IGFs resulted in autophosphorylation of the IGF-IR in an increased proportion of ras bound to GTP and in the association of phosphatidylinositol 3'-kinase (PI3K) activity and of p85-PI3K with M(r) 185,000 phosphotyrosinylated proteins corresponding in size to insulin/IGF-IR substrates. These events were associated with enhanced proliferation. MDA MB-468 is a human breast cancer cell line which expresses insulin receptor and high levels of epidermal growth factor/transforming growth factor alpha receptor but low levels of IGF-IR. In this cell line, insulin stimulated autophosphorylation of IR at physiological concentrations and promoted the association of PI3K activity and of p85 with phosphotyrosine-containing proteins. Insulin did not, however, induce increased ras.GTP, and the cells exhibited minimal proliferation in response to insulin. Unlike insulin treatment, epidermal growth factor stimulation of MDA MB-468 cells is mitogenic and resulted in increased ras.GTP content, suggesting that the failure of insulin to induce these changes is not due to alterations in these signaling molecules. We conclude that there is a postreceptor defect in insulin signaling in MDA MB-468 which prevents the activation of ras and the induction of mitogenesis. Activation of PI3K by insulin is not sufficient to mediate mitogenesis.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
M. Soljic, I. Mrklic, S. Tomic, T. Omrcen, N. Sutalo, M. Bevanda, and E. Vrdoljak
Prognostic value of vitamin D receptor and insulin-like growth factor receptor 1 expression in triple-negative breast cancer
J. Clin. Pathol., August 1, 2017; (2017) jclinpath-2016-204222v2.
[Abstract] [Full Text]


Home page
Endocr Relat CancerHome page
D. P. Rose and L. Vona-Davis
The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression
Endocr. Relat. Cancer, November 9, 2012; 19(6): R225 - R241.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Bartucci, C. Morelli, L. Mauro, S. Ando', and E. Surmacz
Differential Insulin-like Growth Factor I Receptor Signaling and Function in Estrogen Receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 Breast Cancer Cells
Cancer Res., September 1, 2001; 61(18): 6747 - 6754.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Simpson, J. Li, D. Liaw, I. Hennessy, J. Oliner, F. Christians, and R. Parsons
PTEN Expression Causes Feedback Upregulation of Insulin Receptor Substrate 2
Mol. Cell. Biol., June 15, 2001; 21(12): 3947 - 3958.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
L. Sepp-Lorenzino and N. Rosen
A Farnesyl-Protein Transferase Inhibitor Induces p21 Expression and G1 Block in p53 Wild Type Tumor Cells
J. Biol. Chem., August 7, 1998; 273(32): 20243 - 20251.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
J. G. Jackson, M. F. White, and D. Yee
Insulin Receptor Substrate-1 is the Predominant Signaling Molecule Activated by Insulin-like Growth Factor-I, Insulin, and Interleukin-4 in Estrogen Receptor-positive Human Breast Cancer Cells
J. Biol. Chem., April 17, 1998; 273(16): 9994 - 10003.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
L. Sepp-Lorenzino, Z. Ma, D. E. Lebwohl, A. Vinitsky, and N. Rosen
Herbimycin A Induces the 20 S Proteasome- and Ubiquitindependent Degradation of Receptor Tyrosine Kinases
J. Biol. Chem., July 14, 1995; 270(28): 16580 - 16587.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1994 by the American Association of Cancer Research.